Ralph L. Sacco, M.D., M.S., professor and chairman of Neurology and Olemberg Family Chair in Neurological Disorders at the University of Miami Miller School of Medicine, served as senior author of a companion editorial to a study that associates artificially sweetened beverages with stroke and dementia. The study findings and Sacco’s editorial were published in the American Heart Association journal Stroke.
The University of Miami Miller School of Medicine Department of Neurology’s leadership, faculty, and supporters recently celebrated 55 years of excellence during an anniversary celebration at the Biltmore Hotel in Coral Gables. Since its founding in 1962, the Department of Neurology has become a national and international powerhouse providing world-class care in the prevention and treatment of neurological disorders.
William A. Sheremata, M.D., emeritus professor of neurology at the University of Miami Miller School of Medicine, passed away on March 29 – but not before learning that the Food and Drug Administration (FDA) approved a ground-breaking drug for multiple sclerosis.
The American Psychosocial Oncology Society (APOS) selected William F. Pirl, M.D., M.P.H., associate director for Cancer Support Services at Sylvester Comprehensive Cancer Center, for the Outstanding Education and Training Award at its national conference on February 16. APOS grants the annual award to an individual who makes substantial contributions to educating or training others in the field.
The absence of suitable biomarkers for amyotrophic lateral sclerosis (ALS) poses a major obstacle to therapy development. For this reason, the discovery and validation of potential disease progression and pharmacodynamic biomarkers has been one of the top priorities in ALS research.